Volume 6, Issue 2 (12-2019)                   vacres 2019, 6(2): 18-22 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Armandei S, Shahsavandi S, ebrahimi M M. Evaluation of the Effects of Chitosan on Immune Responses due to Infectious Bursal Disease Virus (IBDV) Vaccine in Chicken. vacres 2019; 6 (2) :18-22
URL: http://vacres.pasteur.ac.ir/article-1-176-en.html
Razi Vaccine and Serum Research Institute
Abstract:   (1792 Views)
Introduction: Inactivated Infectious Bursal Disease Virus (IBDV) is administrated against Infectious Bursal Disease (IBD). Chitosan biopolymer is capable of inducing proper immune responses to an antigen while being non-toxic and degradable. In this study, the effect of chitosan on improving the humoral immune responses against IBD virus (IBDV) was investigated. Methods: The antigen was prepared by inoculating IBDV in embryonated chicken eggs and inactivation by ethylenimine. Chitosan solutions at final concentrations of 0.5% and 1% were made and used as an adjuvant. One-day-old chickens were randomly divided in 8 groups and received intramuscularly different profiles of the inactivated antigen and chitosan solution. Serum samples were collected before the prime and booster injection as well as at the defined intervals and assayed by ELISA and serum neutralization tests. Results: After 2-dose intramuscular immunization with inactivated IBDV in combination with chitosan, significant increases (P < 0.05) in antibody titers were observed compared with other administration groups. The addition of 1% chitosan to inactivated IBDV resulted in higher level of neutralizing antibody titer than 0.5% chitosan. However, the difference in the enhancing of antibody titers and the neutralization index between these concentrations was not significant. Conclusion: These data revealed that chitosan as an antigen carrier has the potential to enhance specific immune responses induced by inactived IBDV.
Full-Text [PDF 356 kb]   (612 Downloads)    
Type of Study: Research | Subject: Vaccine production and manufacturing
Received: 2020/03/2

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.